Population
Bradykinin B2 receptor-deleted mice (Bdkrb2-/-)
Comparison
Blockade of Mas with antagonist A-779, combined… vs Untreated Bdkrb2-/- mice or wild-type mice
Design
Preclinical
Authors
Loading...
Mas antagonism accelerates thrombosis in Bdkrb2-/- mice; leaves open any role in human hemostasis.
In Bdkrb2-/- mice, elevated Angiotensin 1-7 and Mas receptor activity delay thrombosis and prolong bleeding by increasing NO and prostacyclin, which can be reversed by Mas blockade.
Fang et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: